Cytosorbents

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: 186

Market Cap: $56.6M

Website

Introduction: CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.

Clinical Trials

CytOSorb TreatMent Of Critically Ill PatientS Registry

Recruiting

Conditions: Cardiogenic Shock
Pancreatitis
Extracorporeal Life Support
Postoperative Endocarditis
Postoperative Vasoplegic Syndrome
Hemophagocytic Lymphohistiocytoses
Trauma
Rhabdomyolysis
Acute on Chronic Liver Failure
Liver Transplant; Complications

First Posted Date: 2021-12-06

Last Posted Date: 2024-08-20

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 3000

Registration Number: NCT05146336

Locations: 🇩🇪
Universitätsklinikum Aachen, Aachen, Germany
🇩🇪
Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum, Bochum, Germany
🇩🇪
Universitätsklinikum Essen, Medizinische Intensivtherapie, Essen, Germany

and more 19 locations

Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)

Not Applicable

Terminated

Conditions: Blood Loss, Postoperative
Hemorrhage Postoperative
Hemorrhage, Surgical
Blood Loss, Surgical

Interventions: Device: DrugSorb-ATR system
Device: Sham comparator

First Posted Date: 2021-10-26

Last Posted Date: 2024-02-09

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 9

Registration Number: NCT05093504

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
Lutheran Medical Group, Fort Wayne, Indiana, United States

and more 24 locations

Safe and Timely Antithrombotic Removal (STAR) Registry

Recruiting

Conditions: Blood Loss, Surgical
Blood Loss, Postoperative
Hemorrhage, Surgical
Hemorrhage Postoperative

First Posted Date: 2021-10-14

Last Posted Date: 2024-08-27

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 1000

Registration Number: NCT05077124

Locations: 🇦🇹
Universitätsklinikum Graz, Graz, Austria
🇦🇹
Medizinische Universität Innsbruck, Innsbruck, Austria
🇦🇹
Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria

and more 22 locations

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

Not Applicable

Completed

Conditions: Blood Loss, Postoperative
Hemorrhage Postoperative
Blood Loss, Surgical
Hemorrhage, Surgical

Interventions: Device: Sham comparator
Device: DrugSorb-ATR system

First Posted Date: 2021-07-26

Last Posted Date: 2024-01-31

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 140

Registration Number: NCT04976530

Locations: 🇺🇸
MedStar Health Research Institute, Washington, District of Columbia, United States
🇨🇦
St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada
🇺🇸
University of Iowa, Iowa City, Iowa, United States

and more 26 locations

Registry of CytoSorb Therapy in COVID-19 ICU Patients

Completed

Conditions: COVID-19

Interventions: Device: CytoSorb 300 mL device

First Posted Date: 2020-05-18

Last Posted Date: 2024-02-09

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 138

Registration Number: NCT04391920

Locations: 🇺🇸
Medical Center of Aurora, Aurora, Colorado, United States
🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
🇺🇸
Franciscan Health Indianapolis, Indianapolis, Indiana, United States

and more 4 locations

Ticagrelor CytoSorb Hemoadsorption

Not Applicable

Terminated

Conditions: Bleeding
Emergent Cardiothoracic Surgery
Drug Removal

Interventions: Device: CytoSorb 300 mL device

First Posted Date: 2019-10-18

Last Posted Date: 2022-03-09

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 5

Registration Number: NCT04131959

Locations: 🇬🇧
Harefield Hospital, Harefield, England, United Kingdom
🇬🇧
Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom
🇬🇧
Manchester Royal Infirmary, Manchester, England, United Kingdom

and more 5 locations

CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery

Not Applicable

Terminated

Conditions: Elective Cardiac Surgery

Interventions: Device: CytoSorb

First Posted Date: 2017-12-28

Last Posted Date: 2024-12-04

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 186

Registration Number: NCT03384875

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
🇺🇸
Baptist Memorial Hospital, Memphis, Tennessee, United States
🇺🇸
Ohio State university, Columbus, Ohio, United States

and more 17 locations

CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery

Not Applicable

Completed

Conditions: Elective Cardiac Surgery

Interventions: Device: CytoSorb

First Posted Date: 2015-10-02

Last Posted Date: 2021-08-20

Lead Sponsor: CytoSorbents, Inc

Target Recruit Count: 52

Registration Number: NCT02566525

Locations: 🇺🇸
Baystate Medical, Springfield, Massachusetts, United States
🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 5 locations

Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis

Phase 2

Withdrawn

Conditions: Rhabdomyolysis

Interventions: Device: CytoSorb Device
Procedure: CVVH

First Posted Date: 2014-04-10

Last Posted Date: 2023-04-07

Lead Sponsor: CytoSorbents, Inc

Registration Number: NCT02111018

Locations: 🇺🇸
San Antonio Military Medical Center- US Army Institute of Surgical Research- Burn Center, San Antonio, Texas, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy